Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A benign histiocytic tumor that occurs during childhood; it is distinct from Langerhans cell histiocytosis. It is characterized by the presence of lipid-laden, foamy histiocytes and Touton-type giant cells in the dermis. The lesions usually develop during infancy. They consist of cutaneous papules and nodules (most often in the head and neck). It is sometimes associated with deep soft tissues nodules.
Biomarker and diagnostic research for juvenile xanthogranuloma has been reported in the published literature.
3 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, and procedural interventions. Pipeline includes 3 PHASE2. Research is primarily sponsored by academic and government institutions.
67 publications have been identified in PubMed for juvenile xanthogranuloma. Research spans Case Report / Case Series (59%), Review / Meta-Analysis (23%), and Other (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 39 |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 7:14 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 15 | 23% |
Other research | 7 | 11% |
Testing and diagnosis research | 3 | 5% |
Laboratory research | 2 | 3% |
Yuan X (2026). [PMID: 42199627](https://pubmed.ncbi.nlm.nih.gov/42199627/). *J Inflamm Res*. [Basic Science / Preclinical]
Fend F (2026). [PMID: 40210741](https://pubmed.ncbi.nlm.nih.gov/40210741/). *Virchows Arch*. [Review / Meta-Analysis]
Däniker M (2026). [PMID: 41170802](https://pubmed.ncbi.nlm.nih.gov/41170802/). *Pediatr Dev Pathol*. [Review / Meta-Analysis]
Askinas CA (2026). [PMID: 41658937](https://pubmed.ncbi.nlm.nih.gov/41658937/). *Plast Reconstr Surg Glob Open*. [Case Report / Case Series]
Labib A (2026). [PMID: 40682442](https://pubmed.ncbi.nlm.nih.gov/40682442/). *Pediatr Dermatol*. [Case Report / Case Series]
Wang H (2026). [PMID: 41899058](https://pubmed.ncbi.nlm.nih.gov/41899058/). *J Clin Med*. [Diagnostic / Biomarker]
Mu A (2026). [PMID: 41502359](https://pubmed.ncbi.nlm.nih.gov/41502359/). *Pediatr Blood Cancer*. [Other]
Ferraz R (2026). [PMID: 41842676](https://pubmed.ncbi.nlm.nih.gov/41842676/). *Arch Argent Pediatr*. [Case Report / Case Series]
Methaprayoon W (2026). [PMID: 41545221](https://pubmed.ncbi.nlm.nih.gov/41545221/). *BMJ Case Rep*. [Case Report / Case Series]
Leung WY (2026). [PMID: 41935961](https://pubmed.ncbi.nlm.nih.gov/41935961/). *Pediatr Blood Cancer*. [Other]